Names | Mode of action | References |
Forskolin | Stimulates adenylate cyclase activity and increases cAMP | [58] |
Valproic acid | Histone deacetylase inhibitor | [85] |
BIO (6-Bromoindirubin | Inhibitor for GSK | [94] |
Lithium | GSK3 Inhibition (Wnt+) | [26] |
CHIR99021 | GSK3 inhibitor | [46] |
Trichostatin | A histone deacetylase inhibitor | [85] |
Sodium Butyrate | Sodium butyrate is a known inhibitor of histone deacetylases and inhibits both the mRNA and protein content of cyclin D1 | [85] |
Parnate | Histone demethylase inhibitor | [86] |
5-azacytidine | DNA methyltransferase inhibitor | [85] |
SC1 (Pluripotin) | Can act as a LIF replacement molecule for mouse embryonic (mES) cell self-renewal | [113] |
RG108 | DNA methyltransferase inhibitor | [87] |
PD0325901 | Selectively binds and inhibits MEK | [46] |
SIRT1 | A class | [90] |
RSC133 | Inhibits histone deacetylase and DNA methyltransferase | [91] |
RepSox | Tgfbr1 kinase inhibitor | [114] |
Etoposide | Notch1 upregulation | [109] |
| Wnt | [109] |
Vitamin C | Nutrient vital that lower reactiveoxygen species | [110] |
Chaetocin | Histone Methyltransferase Inhibition | [109] |
Pifithrin-α | Inhibitor of p53-dependent apoptosis. Moreover, reduced p53 activity augments reprogramming efficiency of human and mouse somatic cells | [111] |
Pifithrin-μ | Inhibitor of p53 mitochondrial pathway by reducing its affinity for antiapoptotic proteins Bcl-2 and Bcl-XL but does not affect any additional transcriptional functions of p53 | [112] |
DNMT1 | Inhibition promote fully reprogramming | [79] |
HDACs | Inhibition increase the efficiency of reprogramming | [85] |
G | Increase the efficiency of reprogramming | [53] |